Home | Family | Family Businesses
A European pharmaceutical company developed a silicon gel "cooling cap", a cancer patient in chemotherapy when wear this kind of hat, will help to prevent trichomadesis. Dignitana by Sweden AB corporation manufacture of this TouKuiShi cooling cap, the design purpose is cooling patients scalp and help them keep hair. At present, in California, United States, there are 20 patients undergoing tests. North American university oncologists Mr Bell said U.S. 50,000 4,000 with early breast cancer patients, has more than 60% in chemotherapy hair falls off entirely. And, according to the clinical oncology statistics, the United States last year have 90 million cancer patients receiing chemotherapy. Mr Bell said, this kind of hat can be scalp cooling to 5 degrees Celsius (41 degrees Fahrenheit), let hair root nearby vascular rapidly shrinking, reduce chemotherapy drugs were hair follicle absorption of degree. This product is still in the trial, some patients said intolerable scalp is cooled to low temperature, others complaints have headaches side effects. This is called DigniCap cooling cap already in Europe, mainly Denmark, Norway and Sweden sales last year, creating a $1 million income (about 128 million proterozoic). The company President Martin said, if the university of California San Francisco, trials of success, the company this year will conduct 100 patient's extended trial. According to the company's website introduces, DigniCa cooling cap includes a clingy scalp of synthetic rubber cap, and a circulating coolant flow of control unit connections. External and a hat, help elastic rubber insulation and ensure cap tighten. Cooling cycle through the temperature sensor to control, can use the valve to adjust. A European pharmaceutical company developed a silicon gel "cooling cap", a cancer patient in chemotherapy when wear this kind of hat, will help to prevent trichomadesis. Dignitana by Sweden AB corporation manufacture of this TouKuiShi cooling cap, the design purpose is cooling patients scalp and help them keep hair. At present, in California, United States, there are 20 patients undergoing tests. North American university oncologists Mr Bell said U.S. 50,000 4,000 with early breast cancer patients, has more than 60% in chemotherapy hair falls off entirely. And, according to the clinical oncology statistics, the United States last year have 90 million cancer patients receiing chemotherapy. Mr Bell said, this kind of hat can be scalp cooling to 5 degrees Celsius (41 degrees Fahrenheit), let hair root nearby vascular rapidly shrinking, reduce chemotherapy drugs were hair follicle absorption of degree. This product is still in the trial, some patients said intolerable scalp is cooled to low temperature, others complaints have headaches side effects. This is called DigniCap cooling cap already in Europe, mainly Denmark, Norway and Sweden sales last year, creating a $1 million income (about 128 million proterozoic). The company President Martin said, if the university of California San Francisco, trials of success, the company this year will conduct 100 patient's extended trial. According to the company's website introduces, DigniCa cooling cap includes a clingy scalp of synthetic rubber cap, and a circulating coolant flow of control unit connections. External and a hat, help elastic rubber insulation and ensure cap tighten. Cooling cycle through the temperature sensor to control, can use the valve to adjust.
Article Source: http://www.gambling-articles.org
My name is Amanda xzh，watchesmanufacturers.com provides China LED Watches, Silicone Watches, welcome to visite Mechanical Watches .
Please Rate this Article
5 out of 54 out of 53 out of 52 out of 51 out of 5
Not yet Rated
